Moxatag FDA Approval History
FDA Approved: Yes (Discontinued) (First approved January 23, 2008)
Brand name: Moxatag
Generic name: amoxicillin
Dosage form: Extended Release Tablets
Treatment for: Tonsillitis/Pharyngitis
Marketing Status: Discontinued
Moxatag is a once-daily extended-release formulation of the penicillin antibiotic amoxicillin indicated for the treatment of adults and pediatric patients 12 years and older with pharyngitis and/or tonsillitis secondary to Streptococcus pyogenes (commonly referred to as strep throat).
Development Timeline for Moxatag
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.